Renal Cell Carcinoma: Natural History and Chemotherapeutic Experience
- 1 September 1975
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 114 (3), 371-374
- https://doi.org/10.1016/s0022-5347(17)67032-0
Abstract
Eght-four patients with renal cell carcinoma were analyzed retrospectively in order to 1) determine the effectiveness of systemic chemotherapy-hormonal and non-hormmonal, 2) identify the clinical features of renal cell carcinoma that may be important in prognosis and 3) characterize the paraneoplastic features of renal cell carcinoma. Metastatic disease was present at diagnosis in 57 per cent of the cases and developed within 1 year in an additional 19 per cent of the cases were paradoxically associated with a longer survival (20 months median) compared to single-organ metastasis (5 to 11 months median). Paraneoplastic syndromes occurred in up to 40 per cent of patients with variable survival. Metastatic disease was unresponsive objectively to either primary nephrectomy or to a variety of chemotherapy trials.Keywords
This publication has 14 references indexed in Scilit:
- Regression of metastatic renal cell carcinoma following nephrectomyCancer, 1972
- Autoantibodies to Human Renal Cell CarcinomaJournal of Urology, 1972
- THE SYSTEMIC EFFECTS OF MALIGNANT RENAL TUMOURS1British Journal of Urology, 1971
- Hormonal therapy in advanced renal cell carcinomaCancer, 1971
- Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 casesCancer, 1971
- Prognosis in renal carcinomaCancer, 1970
- Renal cell carcinoma.Natural history and results of treatmentCancer, 1970
- Progressive Hepatic FailureArchives of Internal Medicine, 1967
- The Current Status of Chemotherapy for Advanced Renal CarcinomaJournal of Urology, 1967
- NEW GROWTHS OF THE KIDNEY AND URETER1British Journal of Urology, 1951